Sickle Cell Disease Treatment Demonstration Regional Collaboratives Program

This announcement solicits applications for the Sickle Cell Treatment Demonstration Regional Collaboratives Program.  The purpose of this funding opportunity is to fund Regional Coordinating Centers (RCC) that will establish regional networks and provide leadership and support for regional and statewide

credit:


activities that will develop and establish systemic mechanisms to improve the prevention and treatment of Sickle Cell Disease, by:
(1) increasing the number of providers treating individuals with sickle cell disease using the National Heart, Lung and Blood Institute (NHLBI) Evidence-Based Management of Sickle Cell Disease Expert Panel Report;[1] (2) using telementoring, telemedicine[2] and other provider support strategies to increase the number of providers administering  evidence-based sickle cell care; and 3) developing and implementing strategies to improve access to quality care with emphasis on individual and family engagement/partnership, adolescent transitions to adult life, and care in a medical home.

[1] National Heart, Lung and Blood Institute (NHLBI) Evidence-Based Management of Sickle Cell Disease Expert Panel Report can be found online.  A quick guide of the recommendations can be found at:
http://www.nhlbi.nih.gov/sites/www.nhlbi.nih.gov/files/Evd-Bsd_SickleCellDis_Rep201 4. pdf  [2] According to the American Telemedicine Association, telemedicine is the use of medical information exchanged from one site to another via electronic communications to improve a patient’s clinical health status.  Telemedicine includes a growing variety of applications and services using two-way video, email, smart phones, wireless tools and other forms of telecommunications technology.  (http://www.americantelemed.org/main/about/telehealth-faqs- )
Related Programs

Sickle Cell Treatment Demonstration Program

Department of Health and Human Services



Relevant Nonprofit Program Categories



Obtain Full Opportunity Text:
Not Available

Additional Information of Eligibility:
Eligible entities for this cooperative agreement program are any federally-qualified health center, nonprofit hospital or clinic, or university health center that provides primary health care that: (1) has a collaborative agreement with a community-based sickle cell disease organization or a nonprofit entity with experience in working with individuals with sickle cell disease; and (2) demonstrates that it, the collaborative entity, or the experts described in section 712(c)(2)(C) of the American Jobs Creation Act of 2004, has at least five (5) years of experience working with individuals who have sickle cell disease.  Faith-based and community-based organizations that meet these qualifications are eligible to apply.

Foreign entities are not eligible for HRSA awards, unless the authorizing legislation specifically authorizes awards to foreign entities or the award is for research.

 This exception does not extend to research training awards or construction of research facilities.



Full Opportunity Web Address:


Contact:
Department of Health and Human Services, Health Resources and Services Administrationeivy@hrsa.gov

Agency Email Description:
Contact Edward Donnell Ivy at (301)443-9775 or email eivy@hrsa.gov

Agency Email:
eivy@hrsa.gov

Date Posted:
2016-11-10

Application Due Date:
2017-01-13

Archive Date:
2017-02-27



Social Entrepreneurship
Spotlight



The Social Innovators of 2014


For 2014, the Schwab Foundation for Social Entrepreneurship has recognized 37 individuals for their outstanding work in the field of social enterprise.






More Federal Domestic Assistance Programs


Unallied Management Projects | Corrections_Research and Evaluation and Policy Formulation | Boll Weevil Eradication Loan Program | Adjustable Rate Mortgages | Title VI - Cheyenne River Sioux Tribe, Lower Brule Sioux Tribe, and Terrestrial Wildlife Habitat Res |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2024 Copyright Michael Saunders